RPS28B Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to RPS28B Antibody

RPS28 antibodies are polyclonal or monoclonal reagents that bind to the RPS28 ribosomal protein, which plays roles in translation and mRNA quality control. These antibodies enable researchers to:

  • Quantify RPS28 protein levels in cellular models

  • Investigate ribosome biogenesis and mRNA decay pathways

  • Study P-body (PB) assembly dynamics, as RPS28 interacts with PB proteins like Edc3

3.1. Protein-Protein Interaction Studies

RPS28 antibodies have been critical in demonstrating:

  • Cis-translational Edc3 binding: Rps28 translated in cis from RPS28B mRNA interacts more strongly with Edc3 than trans-produced Rps28, facilitating PB assembly .

  • Autoregulatory feedback: RPS28 protein levels inversely regulate RPS28B mRNA stability via Edc3-mediated decay .

3.2. Phenotypic Characterization

  • PB assembly defects: rps28aΔ and rps28bΔ yeast strains show 70–100% reduction in PBs under normal growth . Antibodies confirmed Rps28 protein levels remain stable in these mutants .

  • Polysome profiling: RPS28 antibodies helped correlate RPS28B mRNA translation efficiency with PB formation .

Table 2: Performance Metrics for ab241282

ApplicationSample TypeResult
Western BlotHEK-293T lysateClear band at 8 kDa
ImmunoprecipitationHEK-293T lysateEfficient pull-down of RPS28

Table 3: 14796-1-AP Clinical Relevance

Tissue TypePathologyStaining Pattern
Human pancreasAdenocarcinomaCytoplasmic granular staining

Technical Considerations

  • Cross-reactivity: Both antibodies recognize human, mouse, and rat RPS28 .

  • Buffer compatibility: ab241282 uses PBS with 0.02% sodium azide , while 14796-1-AP includes 50% glycerol .

  • Critical controls: Studies using these antibodies included RPS28A/RPS28B knockout strains and IgG-negative controls .

Limitations and Future Directions

  • No isoform-specific antibodies distinguishing Rps28a (S3) from Rps28b (N3) are commercially available.

  • Current tools cannot differentiate between ribosome-bound vs. free RPS28 pools.

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RPS28B antibody; RPS33B antibody; YLR264W antibody; L8479.5 antibody; 40S ribosomal protein S28-B antibody; S33 antibody; Small ribosomal subunit protein eS28-B antibody; YS27 antibody
Target Names
RPS28B
Uniprot No.

Target Background

Function
Ribosomal protein S28B (RPS28B) is a crucial component of the ribosome, a complex macromolecule responsible for protein synthesis within cells. The ribosome comprises two subunits: the small subunit (SSU) and the large subunit (LSU). The SSU binds to messenger RNA (mRNA) and decodes the genetic information encoded within it, selecting the appropriate aminoacyl-transfer RNA (tRNA) molecules. The LSU contains the peptidyl transferase center (PTC), the catalytic site responsible for forming peptide bonds, linking amino acids together into polypeptide chains. Newly synthesized polypeptides exit the ribosome through a tunnel in the LSU, where they interact with protein factors that facilitate their enzymatic processing, targeting, and membrane insertion.
Gene References Into Functions
  1. RPS28B does not directly bind to the 3'-untranslated region (UTR) regulatory element in its own mRNA. Instead, Edc3 protein directly binds to this element, and RPS28B interacts with Edc3 to regulate its activity. PMID: 24492965
Database Links

KEGG: sce:YLR264W

STRING: 4932.YLR264W

Protein Families
Eukaryotic ribosomal protein eS28 family
Subcellular Location
Cytoplasm.

Q&A

What is RPS28B and what cellular functions does it perform?

RPS28B is a protein component of the small ribosomal subunit essential for protein synthesis in eukaryotic cells. It functions as part of the small subunit (SSU) processome, which serves as the first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, RPS28B works alongside numerous ribosome biogenesis factors, RNA chaperones, and other ribosomal proteins to facilitate RNA folding, modifications, rearrangements and cleavage . Recent research has also revealed that RPS28B mRNA plays a critical role as a scaffold for P-body (PB) assembly, suggesting functions beyond its role in translation .

What are the key differences between RPS28A and RPS28B proteins?

While RPS28A and RPS28B are paralogous proteins in yeast with similar primary functions in ribosomal assembly, they demonstrate significant functional differences in P-body formation. Deletion studies show that both genes affect P-body assembly under normal growth conditions, with rps28bΔ showing approximately 100% reduction in P-bodies per cell and rps28aΔ showing approximately 70% reduction . The RPS28B mRNA itself has been found to act as a scaffold for P-body assembly due to its unusually long 3'UTR that interacts with Edc3, a major P-body assembly factor, whereas RPS28A mRNA lacks this scaffolding capability .

What antibody formats are available for RPS28B research?

The primary antibody format available for RPS28B research is a rabbit polyclonal antibody that recognizes both human and mouse RPS28. This antibody has been validated for immunoprecipitation (IP) and Western blot (WB) applications . For detection in Western blotting applications, researchers typically use this primary antibody at a 1:2500 dilution, while for immunoprecipitation, a 1:500 dilution is recommended . Secondary antibody options include fluorescently labeled antibodies such as IRDye 800CW Goat anti-Rabbit IgG (H + L), which enables detection using imaging systems like the Li-Cor Odyssey .

What are the optimal protocols for Western blotting using RPS28B antibodies?

For optimal Western blotting results with RPS28B antibodies, researchers should follow this protocol:

  • Load protein extracts onto SDS-polyacrylamide gels

  • Transfer proteins to an appropriate membrane

  • Block the membrane using standard blocking buffer

  • Incubate with rabbit anti-RPS28 primary antibody at a 1:2500 dilution

  • Wash thoroughly with TBST or PBST buffer

  • Incubate with IRDye 800CW Goat anti-Rabbit IgG secondary antibody

  • Visualize using a fluorescence imaging system such as the Li-Cor Odyssey

For quantitative analysis, include a loading control such as GAPDH (detected using Mouse anti-GAPDH at 1:25000 dilution) . This approach allows for accurate quantification of RPS28 protein levels across different experimental conditions.

How can I optimize immunoprecipitation experiments with RPS28B antibodies?

For effective immunoprecipitation of RPS28B-interacting complexes, follow this optimized protocol:

  • Harvest cells at mid-log phase (OD₆₀₀ ~0.6)

  • Freeze cell pellets in liquid nitrogen for storage

  • Lyse cells in buffer containing 50 mM Tris (pH 7.4), 1 mM EDTA, 150 mM NaCl, and 0.5% NP-40, supplemented with fungal-specific protease inhibitor (1 μl/100 μl) and 1 mM PMSF

  • Disrupt cells using glass beads with vortexing (3 min at 4°C followed by 2 min rest on ice, repeated twice)

  • Centrifuge at 2000g for 2 min at 4°C

  • Incubate supernatant with equilibrated GFP-Trap-MA beads for 1 hour with rotation

  • Wash 4 times with buffer (excluding NP-40)

  • Elute bound proteins with SDS sample loading buffer at 95°C for 10 min

  • Detect RPS28 using anti-RPS28 antibody at 1:500 dilution

This protocol is particularly effective for studying RPS28B interactions with other proteins such as Edc3, which has been shown to significantly affect P-body assembly.

What methods can be used to visualize RPS28B mRNA localization in cells?

For visualizing RPS28B mRNA localization, fluorescence in situ hybridization (FISH) provides excellent results when performed using this methodology:

  • Design specific Stellaris FISH probes for RPS28B using the Stellaris Probe designer

  • Fix cells using appropriate fixation buffer

  • Perform spheroblasting using buffer containing components similar to immunofluorescence protocols

  • Hybridize probes at 32°C rather than the standard temperature

  • Visualize using fluorescence microscopy systems like Deltavision Elite (100x objective)

  • Analyze images using software such as Fiji

For quantitative assessment, examine a minimum of 100 cells per replicate with at least 3 biological replicates to ensure statistical significance. This approach allows visualization of RPS28B mRNA localization within cellular compartments and its potential co-localization with P-body markers.

How does the RPS28B 3'UTR contribute to P-body assembly mechanisms?

The RPS28B 3'UTR plays a critical role in P-body assembly through multiple mechanisms:

  • Scaffolding Function: The unusually long 3'UTR of RPS28B mRNA serves as a nucleation site for P-body assembly by interacting with Edc3, a major P-body assembly factor .

  • cis-Translational Effects: The RPS28B mRNA uniquely facilitates interaction between newly synthesized Rps28 protein and Edc3 when the RPS28B ORF and its 3'UTR are present on the same transcript (in cis arrangement). This spatial proximity effect significantly enhances protein-protein interactions critical for P-body formation .

  • Comparative UTR Activity: When chimeric constructs containing different ORFs (PGK1, RPS28A, RPS28B, or reverse complement RPS28B) were fused to RPS28B 3'UTR, only those expressing RPS28A or RPS28B ORFs with the RPS28B 3'UTR could rescue P-body assembly in rps28bΔ strains .

This research demonstrates that the regulatory functions of mRNA extend beyond mere protein-coding capacity to include structural roles in cellular assembly processes.

What experimental approaches can resolve contradictory findings in RPS28B protein expression studies?

When encountering contradictory findings regarding RPS28B protein expression, researchers should employ a multi-faceted approach:

Recent studies demonstrated that while RPS28B mRNA abundance did not directly correlate with P-body assembly phenotypes, the combination of non-translating RPS28B mRNA and the cis-translational interaction between Rps28 protein and Edc3 was critical for proper P-body formation .

What are the latest approaches for studying RPS28B interactions with the P-body assembly machinery?

Cutting-edge approaches for investigating RPS28B interactions with P-body assembly machinery include:

  • Chimeric mRNA Expression Systems: Creating fusion constructs with varying combinations of ORFs and UTRs to dissect the specific contributions of each element to protein-protein interactions and P-body assembly .

  • Microscopy with Quantitative Image Analysis: Using Deltavision Elite (100x objective) imaging coupled with Fiji software analysis to quantify P-body formation under different genetic conditions. This approach requires examination of at least 100 cells per replicate across a minimum of 3 biological replicates .

  • Co-immunoprecipitation with Multiple Markers: Performing immunoprecipitation using GFP-tagged P-body components (like Edc3-GFP) followed by Western blotting for RPS28 to assess protein-protein interactions under various conditions .

  • trans vs. cis Expression Analysis: Comparing the effects of supplying RPS28B ORF and 3'UTR on the same transcript (cis) versus on separate transcripts (trans) to understand spatial regulation of protein-protein interactions .

These advanced approaches have revealed that the presence of RPS28B ORF and 3'UTR on the same transcript significantly enhances Edc3-Rps28 protein interaction, highlighting the importance of spatial proximity in molecular assembly processes .

What controls should be included when evaluating RPS28B antibody specificity?

To ensure RPS28B antibody specificity, researchers should implement the following controls:

Control TypeImplementation MethodExpected OutcomeInterpretation
Genetic knockoutUse rps28bΔ strainReduced or absent signalConfirms antibody specifically detects RPS28B
Paralog comparisonCompare signal in rps28aΔ vs. rps28bΔDifferent signal patternsHelps distinguish paralog-specific recognition
Loading controlInclude anti-GAPDH (1:25000 dilution)Consistent GAPDH signalEnsures equal loading across samples
Secondary-onlyOmit primary antibodyNo specific signalRules out non-specific secondary binding
Peptide competitionPre-incubate antibody with immunizing peptideBlocked specific signalConfirms epitope-specific binding

For Western blotting applications, researchers should expect to observe a band corresponding to the molecular weight of RPS28 (approximately 7.8 kDa), with signal intensity proportional to protein expression levels .

How should researchers interpret discrepancies between RPS28B mRNA levels and protein expression?

When faced with discrepancies between RPS28B mRNA and protein levels, researchers should consider several explanations:

  • Translational Regulation: Research has shown that RPS28B mRNA can be more heavily translated in compensatory conditions (e.g., in rps28aΔ strains), leading to maintained protein levels despite altered mRNA abundance .

  • Sequestration Effects: The RPS28B mRNA may be sequestered in heavier polysomes during active translation, preventing its participation in other cellular processes like P-body scaffolding, even when total mRNA levels appear adequate .

  • Threshold Effects: Critical functions may require a threshold amount of non-translating RPS28B mRNA rather than total mRNA abundance. This non-translating fraction is what enters into and scaffolds cellular structures like P-bodies .

  • Paralog Compensation: Increased expression of RPS28A may compensate for RPS28B deficiency at the protein level, masking effects at the mRNA level .

Researchers should implement polysome profiling alongside standard RT-qPCR and Western blotting to properly interpret such discrepancies, as this will reveal the translation status of the mRNA in addition to its abundance.

What factors can influence the reproducibility of RPS28B antibody-based experiments?

Several factors can significantly impact the reproducibility of experiments utilizing RPS28B antibodies:

  • Antibody Dilution Optimization: The optimal dilution varies by application—1:2500 for Western blots and 1:500 for immunoprecipitation. Deviations from these ratios can affect signal-to-noise ratios .

  • Lysis Conditions: The composition of lysis buffer significantly affects antibody performance. For optimal results, use 50 mM Tris (pH 7.4), 1 mM EDTA, 150 mM NaCl, and 0.5% NP-40 with protease inhibitors .

  • Growth Phase Considerations: Harvest cells at consistent growth phases (mid-log, OD₆₀₀ 0.3-0.6) as RPS28B expression and interactions may vary with growth conditions .

  • Strain Background Effects: Different yeast or cell strain backgrounds may exhibit varying levels of RPS28 protein expression or antibody cross-reactivity. Always match experimental and control strains carefully .

  • Sample Preparation Consistency: Inconsistent sample preparation, particularly freezing and thawing cycles, can lead to protein degradation and variable results. Flash-freeze samples in liquid nitrogen and store at -80°C until use .

By controlling these variables, researchers can significantly improve the reproducibility and reliability of their RPS28B antibody-based experiments.

What emerging techniques might enhance our understanding of RPS28B function beyond ribosomal protein synthesis?

Several emerging techniques show promise for expanding our understanding of RPS28B's non-canonical functions:

  • Proximity Labeling Approaches: Techniques like BioID or APEX2 fused to RPS28B could identify novel interaction partners in living cells, potentially revealing functions beyond ribosomal assembly and P-body formation.

  • Single-molecule RNA Imaging: Advanced technologies like MS2-tagging combined with super-resolution microscopy could track individual RPS28B mRNA molecules in real-time, providing insights into their dynamic scaffolding behaviors .

  • Phase Separation Assays: In vitro reconstitution of liquid-liquid phase separation using purified components could determine the direct contribution of RPS28B mRNA to biomolecular condensate formation, building on observations that RNAs can drive phase separation .

  • Cryo-electron Microscopy: Structural studies of RPS28B-containing complexes could reveal the molecular architecture of how RPS28B mRNA and protein contribute to various cellular assemblies.

  • CRISPR-based mRNA Tracking: CRISPR-Cas techniques adapted for RNA visualization could provide new tools for tracking RPS28B mRNA localization and interactions in living cells.

These approaches could help resolve current questions about the dual functionality of RPS28B as both a ribosomal protein and a regulatory RNA with structural roles in cellular organization.

How might research on RPS28B inform our understanding of ribosomopathies and related disorders?

Research on RPS28B has significant implications for understanding ribosomopathies—disorders caused by ribosomal protein defects:

  • Non-canonical Functions: The discovery that RPS28B mRNA acts as a scaffold for P-body assembly suggests ribosomal proteins and their mRNAs may have functions beyond protein synthesis, potentially explaining why ribosomopathies often affect specific tissues despite ribosomes being ubiquitous .

  • Spatial Coupling Mechanisms: The cis-translational enhancement of Rps28-Edc3 interaction reveals mechanisms by which spatial proximity influences protein-protein interactions, which may be disrupted in disease states .

  • Compensatory Mechanisms: Studies showing how cells compensate for RPS28A deletion through increased RPS28B translation provide insights into adaptive responses that may be relevant to therapeutic approaches for ribosomopathies .

  • RNA-Based Scaffolding: The role of RPS28B mRNA as a scaffold highlights how RNA structural elements might contribute to cellular organization, suggesting potential RNA-targeted therapeutic approaches .

  • P-body Dysfunction Connection: Links between RPS28B and P-body assembly suggest that ribosomopathies might involve dysregulation of RNA granules, potentially connecting ribosomal protein defects to broader RNA metabolism disorders.

These research directions could ultimately lead to novel therapeutic approaches targeting not just ribosomal protein production but also their non-canonical functions in cellular organization.

What are the key considerations for designing a comprehensive RPS28B research project?

When designing comprehensive research on RPS28B, investigators should consider these essential elements:

By incorporating these considerations, researchers can develop projects that address both canonical and non-canonical functions of RPS28B, potentially revealing novel therapeutic targets and biological principles.

What standardized protocols should be adopted for consistent RPS28B antibody-based research across laboratories?

To ensure consistency in RPS28B antibody research across different laboratories, the following standardized protocols are recommended:

ProcedureStandardized ProtocolCritical Parameters
Western Blotting1:2500 dilution of anti-RPS28 antibody; IRDye 800CW secondary antibody; GAPDH loading control at 1:25000Protein extraction buffer composition; blocking reagent; incubation times
Immunoprecipitation1:500 dilution of anti-RPS28 antibody; capture with protein A/G beads or direct conjugationCell lysis conditions; wash stringency; elution method
MicroscopyFixation in standard buffer; 100x objective; minimum 100 cells per replicate × 3 replicatesFixation time; imaging parameters; quantification method
FISHStellaris FISH probes; hybridization at 32°C; specific probe design for RPS28BProbe concentration; hybridization conditions; wash stringency
Polysome AnalysisHarvest at mid-log phase (OD₆₀₀ 0.3-0.6); standard sucrose gradientCell lysis method; gradient preparation; fraction collection

Additionally, all experiments should include appropriate positive and negative controls, including genetic knockouts (rps28bΔ) and paralog comparisons (rps28aΔ) to ensure specificity and reliability of results across research groups .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.